101 related articles for article (PubMed ID: 35230875)
1. COVID-19 Disease in Syrian Patients With Cancer: Clinical Manifestations, Laboratory Findings, Treatment, and Outcomes.
Najjar M; Albuaini S; Fadel M; Aljbawi A; Mohsen F; Sulaiman S; Koudsi A
JCO Glob Oncol; 2022 Mar; 8():e2100283. PubMed ID: 35230875
[TBL] [Abstract][Full Text] [Related]
2. Impact of comorbidities on hospitalised Syrian patients with COVID-19: a retrospective study.
Najjar M; Albuaini S; Fadel M; Aljbawi A; AlAwad Y; Mohsen F
BMJ Open; 2023 Mar; 13(3):e068849. PubMed ID: 36940947
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China.
Zhang H; Wang L; Chen Y; Wu Q; Chen G; Shen X; Wang Q; Yan Y; Yu Y; Zhong Y; Wang X; Chua MLK; Xie C
Cancer; 2020 Sep; 126(17):4023-4031. PubMed ID: 32573776
[TBL] [Abstract][Full Text] [Related]
4. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
[No Abstract] [Full Text] [Related]
8. Ninety-day mortality and clinical outcomes of patients with solid tumours and COVID-19 infection during the first pandemic outbreak in Catalonia, Spain: A multicentre retrospective study.
Tapia JC; Gavira J; López A; Llobera L; Pallise O; Marsal I; Cochs A; Ponce OJ; Riudavets M; Gich I; Barnadas A; Majem M
Int J Cancer; 2022 Apr; 150(8):1310-1317. PubMed ID: 34921732
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical outcomes and risk factors for COVID-19 infection in cancer patients without anticancer treatment and noncancer patients.
Yang S; Zhao H; Cui R; Ma L; Ge X; Fu Q; Yu D; Niu X
Front Public Health; 2022; 10():925519. PubMed ID: 36033814
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
12. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
13. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes in cancer patients with COVID-19 in Sweden.
Bondeson L; Thulin A; Ny L; Levin M; Svensson J; Lindh M; Zhao Z
Acta Oncol; 2021 Dec; 60(12):1572-1579. PubMed ID: 34530692
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory characteristics of patients with novel coronavirus disease-2019 infection and deep venous thrombosis.
Motaganahalli RL; Kapoor R; Timsina LR; Gutwein AR; Ingram MD; Raman S; Roberts SD; Rahman O; Rollins D; Dalsing MC
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):605-614.e2. PubMed ID: 33190816
[TBL] [Abstract][Full Text] [Related]
16. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome.
Lo Vecchio A; Garazzino S; Smarrazzo A; Venturini E; Poeta M; Berlese P; Denina M; Meini A; Bosis S; Galli L; Cazzato S; Nicolini G; Vergine G; Giacchero R; Ballardini G; Dodi I; Salvini FM; Manzoni P; Ferrante G; Quadri V; Campana A; Badolato R; Villani A; Guarino A; Gattinara GC;
JAMA Netw Open; 2021 Dec; 4(12):e2139974. PubMed ID: 34928354
[TBL] [Abstract][Full Text] [Related]
18. High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study.
Elkrief A; Desilets A; Papneja N; Cvetkovic L; Groleau C; Lakehal YA; Shbat L; Richard C; Malo J; Belkaid W; Cook E; Doucet S; Tran TH; Jao K; Daaboul N; Bhang E; Loree JM; Miller WH; Vinh DC; Bouganim N; Batist G; Letendre C; Routy B
Eur J Cancer; 2020 Nov; 139():181-187. PubMed ID: 33035991
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020.
Kim SW; Kim SM; Kim YK; Kim JY; Lee YM; Kim BO; Hwangbo S; Park T
J Korean Med Sci; 2021 Jan; 36(1):e12. PubMed ID: 33398946
[TBL] [Abstract][Full Text] [Related]
20. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
